Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lograsso

Showing results (111-120 of 127) with videos related to

Pageof 13
Sort By:
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitorsRomain Noël, Youseung Shin, Xinyi Song, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitorsYuanjun He, Theodore M Kamenecka, Youseung Shin, et al.
Journal of Biomolecular Screening|January 30, 2008
Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)Thomas Schröter, Dmitriy Minond, Amiee Weiser, et al.
Scientific Data|April 1, 2022
Caltech Conte Center, a multimodal data resource for exploring social cognition and decision-makingDorit Kliemann, Ralph Adolphs, Tim Armstrong, et al.
ACS Chemical Neuroscience|June 14, 2011
Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's DiseaseJeremy W Chambers, Alok Pachori, Shannon Howard, et al.
Journal of Medicinal Chemistry|December 2, 2009
Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitorsTed Kamenecka, Rong Jiang, Xinyi Song, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitorsXingang Fang, Yen Ting Chen, E Hampton Sessions, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The development of benzimidazoles as selective rho kinase inhibitorsE Hampton Sessions, Michael Smolinski, Bo Wang, et al.
Journal of Medicinal Chemistry|January 27, 2015
Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitorsYan Yin, Ke Zheng, Nibal Eid, et al.
Physical Review Letters|July 9, 2016
Itinerant and Localized Magnetization Dynamics in Antiferromagnetic HoL Rettig, C Dornes, N Thielemann-Kühn, et al.
Pageof 13

Showing results (111-120 of 127) with videos related to

Sort By:
Pageof 13
Bioorganic & Medicinal Chemistry Letters|December 28, 2010
Synthesis and SAR of 4-(pyrazol-3-yl)-pyridines as novel c-jun N-terminal kinase inhibitorsRomain Noël, Youseung Shin, Xinyi Song, et al.
Bioorganic & Medicinal Chemistry Letters|February 15, 2011
Synthesis and SAR of novel quinazolines as potent and brain-penetrant c-jun N-terminal kinase (JNK) inhibitorsYuanjun He, Theodore M Kamenecka, Youseung Shin, et al.
Journal of Biomolecular Screening|January 30, 2008
Comparison of miniaturized time-resolved fluorescence resonance energy transfer and enzyme-coupled luciferase high-throughput screening assays to discover inhibitors of Rho-kinase II (ROCK-II)Thomas Schröter, Dmitriy Minond, Amiee Weiser, et al.
Scientific Data|April 1, 2022
Caltech Conte Center, a multimodal data resource for exploring social cognition and decision-makingDorit Kliemann, Ralph Adolphs, Tim Armstrong, et al.
ACS Chemical Neuroscience|June 14, 2011
Small Molecule c-jun-N-terminal Kinase (JNK) Inhibitors Protect Dopaminergic Neurons in a Model of Parkinson's DiseaseJeremy W Chambers, Alok Pachori, Shannon Howard, et al.
Journal of Medicinal Chemistry|December 2, 2009
Synthesis, biological evaluation, X-ray structure, and pharmacokinetics of aminopyrimidine c-jun-N-terminal kinase (JNK) inhibitorsTed Kamenecka, Rong Jiang, Xinyi Song, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2011
Synthesis and biological evaluation of 4-quinazolinones as Rho kinase inhibitorsXingang Fang, Yen Ting Chen, E Hampton Sessions, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The development of benzimidazoles as selective rho kinase inhibitorsE Hampton Sessions, Michael Smolinski, Bo Wang, et al.
Journal of Medicinal Chemistry|January 27, 2015
Bis-aryl urea derivatives as potent and selective LIM kinase (Limk) inhibitorsYan Yin, Ke Zheng, Nibal Eid, et al.
Physical Review Letters|July 9, 2016
Itinerant and Localized Magnetization Dynamics in Antiferromagnetic HoL Rettig, C Dornes, N Thielemann-Kühn, et al.
Pageof 13